O GoConqr está de visual novo! Conte para nós o que você achou.

Mapa mental

Diabetes

Tia Jackson PHAM1003 First Year Inglês

Diabetes

Conteúdo do mapa

Diabetes

  1. Types

    • Dibetes Mellitus
    • Diabetes Insipidus
      • ADH deficiency
    • Secondary Diabetes
      • Physical/emotional stress
        • Prolonged elevation of stress hormones (cortisol & noradrenaline
        • Elevation of glucagon & GH
      • Pregnancy (gestational diabetes)
        • Weight gain & increased oestrogen
      • Drugs
        • Corticosteroids & oral contraceptives antagonise insulin's actions
      • Viral infections
        • Mumps & rubella virus can attack pancreas
  2. Diabetes Mellitus

    • Diagnostic indicators
    • Type 1
      • Symptomology
        • Rapidly developing symptoms
        • Muscle wasting
        • Loss of subcutaneous fat
        • Lactosis & acidosis
        • With symptoms apparent, 80% of islets are disabled
        • Anti-insulin and islet antibodies
      • Cause
        • Beta cells in pancreas destroyed or suppressed
        • No insulin produced
      • Treatment
        • Insulin
        • Personalised meal plan
        • Control blood glucose
        • Consistent healthy diet
        • Exercise
      • Insulin-dependent
    • Type 2
      • Cause
        • 1. Insulin resistance at target tissues
        • 2. Overproduction of glucose (inappropriate liver gluconeogenesis)
        • 3. Abnormal insulin secretion
        • 4. Obesity (huge demands on pancreas)
      • Treatment
        • First line treatment
          • Positive lifestyle changes
        • Second line treatment
          • Sensitisers
            • Metaformin (higher uptake of glucose & lower liver glucose output
            • Thiazolidinedione (better use of glucose by cells)
          • Secretagogues
            • Tolubamide, gliclazide (trigger insulin release
              • Must have partially functional beta cells
      • Development
        • 1. Obesity
        • 2. Insulin resistance
        • 3. Hyperinsulinaemia
        • 4. Diminished insulin secretion
        • 5. Type 2 DM
      • Non-insulin dependent
      • 3% UK population (2/3 have type II)
      • Symptomology
        • Vague
        • Slow to develop
        • Long-standing
    • Symptoms
      • Excessive urination (polyuria)
      • Excessive thirst (polydipsia)
      • Excessive eating (polphagia)
      • Weight loss
      • Fatigue & weakness
      • Vision changes
      • Frequent skin infections
      • Dry, itchy skin
      • Vaginal discomfort
  3. Pre-diabetic

    • Impaired glucose tolerance
      • Fasting plasma glucose conc <7.0mmol/l
      • 2hr OGTT (Oral Glucose Tolerance Test) >/= 7.8 and <11.1mmol/l
      • 17% of UK 35-65 age group
      • Hyperglycaemia & insulin resistance
      • Asymptomatic (no symptoms)
      • Risk for cardiovascular disease
      • Risk factors
        • Obesity
        • 1st degree rlatives with type 2 DM
        • Asian/Afro-Caribbean
        • Hypertension
    • Metabolic Syndrome
      • Risk factors that increase risk of cardiovascular disease, diabetes & stroke
      • Any 3 of the following:
        • High waist circumference (>102cm men & 88cm women)
        • High triglycerides (>1.7mmol/l)
        • Low HDL cholersterol (<1.03mmol/l men & 1.29mmol/l women)
        • High blood pressure (>130/85mm Hg)
        • Fasting plasma glucose >5.6mmol/l
  4. Diagnosis

    • Glycosylated Haemoglobin HbA1c
      • New to diagnostic criteria (Jan 2011)
      • >/=6.5% in venous blood
      • Index of glycaemic control
      • Identifies average plasma glucose conc over time (120days)
      • Poor glycaemic control correlates with long-term complications
      • HbA1c is haemoglobin that is glucose bound
      • Expressed at % glycation
    • Hyperglycaemia
    • Fasting venous blood test >/=7.0mmol/l
    • Glucose tolerance test
      • Fasting blood glucose
      • Blood glucose 0.5 - 3hrs after drinking 75g glucose in 300ml water (30 min intervals)
      • >/=11.1mmol/l
  5. Insulin preparations

    • Administered subcutaneously
    • Rate of absorption can be varied by
      • Increase particle size
      • Complex insulin with zinc
    • Short acting
      • Onset 30mins; Peaks 2-4hrs; subsides 8hrs
    • Intermediate/Long acting
      • 16-35hrs
      • Semilente
    • Fast acting
      • Lispro/Aspart
  6. Self-monitoring

  7. Screening

    • Increased risk
      • >40
      • Obesity
      • Asian/Afro-Caribbean
      • Family history of Tyoe 2
      • History of gestational diabetes
      • History of large baby >4Kg
    • Why Screen?
      • Type 2: 9-12 year latency
      • Prevent macrovascular changes (atherosclerosis, hypertension, stroke & MI); and microvascular changes (nephropathy, retinopathy, neuropathy)
    • BMI
      • =Weight (Kg) / Height x Height (m)
        • <18.5 underweight
        • 18.5-25 normal
        • 25-30 overweight
        • >30 obese
  8. Glycaemia & Ketosis

    • Hypo
      • Sudden moodiness
      • Jerky movements
      • Difficulty paying attention
      • Tingling sensations around mouth
    • Hyper
      • Causes: Eating more than planned; exercising less than planned; the stress of an illness
    • Ketosis
      • Build up of ketone bodies from lipid breakdown in liver
      • Can cause acidotic state & diabetic coma
      • Shortness of breath, fruity smell; nausea & vomiting; dry mouth
  9. Quick treatment

    • If a diabetic patient passes out from hypoglycemia:
    • NOT inject insulin
    • NOT give food or fluids
    • DO inject glucagon

Imagens e arquivos do mapa

  • Diabetes

Informações

Descrição
First Year PHAM1003 (Endocrinology) Mapa Mental sobre Diabetes, criado por Tia Jackson em 06-01-2016.
Criado por
Tia Jackson
Visualizações
0
Avaliação

Fale Conosco

Sobre o que é sua mensagem?

O que você acha do novo visual?

Você gostou?